which glp 1 agonists have cardiovascular benefit benefits of glucagon-like peptide-1 receptor GLP-1 Receptor Agonists: The Game-Changer

[PubMed] [Google Scholar] 327.Rocca A.S., Brubaker P.L

Midler et al

doi: 10.1038/s41574-022-00783-3

Heart rate effects during different phases of retatrutide use The cardiovascular response to retatrutide is not static

Although experimental studies suggest potential pancreatic harm from GLP-1 RAs, robust clinical evidence demonstrates that these drugs do not increase the incidence of pancreatitis or pancreatic cancer in diverse human populations

Glp1r expression is undetectable by quantitative PCR in peritoneal or adipose tissue macrophages (37), although Lyz2 -Credriven deletion of Glp1r ( Glp1r Lyz2/ ) abolishes expression in bone marrowderived macrophages (38)